arrow
C

Clara Montagut

centro de investigación biomédica en red cáncer (ciberonc)
H指数:37
被引数:7,750

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors

ColoStem,一种核心胚胎性癌标志物,用于识别预后不良的结直肠肿瘤

2025-12-100
OA
Clinical validation of liquid biopsy-RECIST (LB-RECIST) in metastatic colorectal cancer (mCRC) patients: findings from the PLATFORM-B study

液体活检-实体瘤治疗反应评价标准(LB-RECIST)在转移性结直肠癌(mCRC)患者中的临床验证:PLATFORM-B研究的结果

2025-09-030
OAAI
A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer

一种基于放射组学的人工智能模型,用于评估局部结肠癌的复发风险

2025-07-160
OAAI
Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future Perspectives

结直肠癌腹膜癌病的液体活检:当前证据与未来展望

CANCERS
IF4.4
2025-04-260
OA
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment
2024-07-013
OAAI
Development and validation of an artificial-intelligence-based pathomics biomarker to predict resistance to first-line treatment in metastatic colorectal cancer
2024-03-220
PRE
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402
2023-07-056
PRE
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy
2023-02-1038
OAAI
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

ESMO关于癌症患者使用循环肿瘤DNA检测的建议: 来自ESMO精准医学工作组的报告

2022-08-01264
OA
Cetuximab rechallenge in RAS, BRAF, EGFR-ECD wild type metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies in first line: The CITRIC study
2022-06-018
OA
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis
2022-05-2328
OAAI
Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
EJSO
IF2.9
2022-05-013
PRE
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial
2021-12-0129
OAAI
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper

ctDNA在结直肠癌中的应用和整合: NCI结肠和直肠-肛门工作组白皮书

2020-07-06233
OAAI